InvestorsHub Logo
Followers 137
Posts 22855
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Wednesday, 06/05/2019 9:30:47 PM

Wednesday, June 05, 2019 9:30:47 PM

Post# of 255
AXOVANT ANNOUNCES GLOBAL LICENSING AGREEMENT FOR AXO-AAV-OPMD PROGRAM FOR TREATMENT OF OCULOPHARYNGEAL MUSCULAR DYSTROPHY AND BROADER PLATFORM COLLABORATION WITH BENITEC BIOPHARMA

********************************************************************

Request for Trading Halt
In accordance with ASX Listing Rule 17.1, Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ:
BNTCW) (Benitec) requests a trading halt of its securities, effective immediately.
For the purposes of the trading halt, Benitec provides the following information:
(a) Benitec is seeking the trading halt as it expects to make an announcement to the ASX in relation to one of its
existing material contracts;
(b) Benitec requests the trading halt be put in place until the earlier of the commencement of trading on Tuesday 11
June 2019, or when an announcement is released to the market; and
(c) Benitec is not aware of any reason why the trading halt should not be granted or of any other information
necessary to inform the market about the trading halt.
Should you have any queries in relation to this trading halt request, please do not hesitate to contact me.
Yours faithfully
Oliver Kidd
Company Secretary

https://blt.irmau.com/irm/PDF/2071_0/TradingHalt

https://blt.irmau.com/irm/PDF/2069_0/Becomingasubstantialholder

What's up???

Good luck and GOD bless,

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.